ZFYVE1 Inhibitors
Chemical inhibitors of ZFYVE1 exploit various biochemical mechanisms to hinder the protein's function. LY294002 and Wortmannin are compounds that target phosphoinositide 3-kinases (PI3Ks), which are crucial for the production of phosphatidylinositol 3-phosphate (PI3P). By inhibiting PI3Ks, these chemicals reduce the levels of PI3P, a lipid molecule that ZFYVE1 binds to as part of its normal function. This binding is essential for the role of ZFYVE1 in signaling pathways and membrane trafficking. Similarly, 3-Methyladenine, another PI3K inhibitor, disrupts autophagy by impeding the generation of PI3P, which is vital for the formation of autophagosomal membranes where ZFYVE1 is active. Autophinib, by targeting VPS34, a class III PI3K, also reduces PI3P, thus indirectly inhibiting the involvement of ZFYVE1 in autophagy.
Continuing with the theme of disrupting PI3P levels, Spautin-1 and SAR405 specifically inhibit components of the VPS34 PI3K complex. Spautin-1 increases the degradation of these components through its action on deubiquitinating enzymes, while SAR405 directly inhibits VPS34, thereby both leading to a decrease in PI3P production. This decrease has a consequential effect on ZFYVE1, which relies on PI3P for its autophagic function. Other inhibitors, such as SB203580 and U0126, act upstream in signaling cascades. SB203580 inhibits p38 MAPK, and U0126 targets MEK1/2, both of which are kinases that can influence the activity of ZFYVE1. Inhibition of these kinases can alter the signaling processes that regulate ZFYVE1 function. PD98059, another MEK inhibitor, similarly affects MAPK/ERK signaling, with downstream effects on ZFYVE1 activity. Bafilomycin A1 and Concanamycin A, as inhibitors of V-ATPase, prevent the acidification of vesicles, including autophagosomes and endosomes, disrupting the environment necessary for ZFYVE1's function in membrane trafficking. Meanwhile, Chloroquine raises the pH in lysosomes and autophagosomes, which can inhibit the function of ZFYVE1 associated with these organelles.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a phosphoinositide 3-kinase (PI3K) inhibitor. ZFYVE1 is known to bind phosphatidylinositol 3-phosphate, a product of PI3K. Inhibiting PI3K with LY294002 can reduce the production of phosphatidylinositol 3-phosphate, thereby reducing ZFYVE1's ability to bind to its substrate and perform its function. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is another PI3K inhibitor. Similar to LY294002, it can decrease the levels of phosphatidylinositol 3-phosphate in the cell, which is necessary for ZFYVE1's function. By limiting the availability of this lipid, Wortmannin can inhibit ZFYVE1's activity. | ||||||
Autophagy Inhibitor, 3-MA | 5142-23-4 | sc-205596 sc-205596A | 50 mg 500 mg | $65.00 $261.00 | 113 | |
3-Methyladenine is a class III PI3K inhibitor that can inhibit autophagy, a process in which ZFYVE1 is implicated due to its involvement in early autophagosomal membranes. This chemical can inhibit the autophagic function of ZFYVE1 by reducing the formation of PI3P, impairing autophagosome formation. | ||||||
Spautin-1 | 1262888-28-7 | sc-507306 | 10 mg | $168.00 | ||
Spautin-1 is known to inhibit the deubiquitinating enzymes USP10 and USP13, leading to an increase in the ubiquitination and degradation of VPS34 PI3K complex components. Since ZFYVE1 relies on PI3P produced by VPS34, Spautin-1 indirectly inhibits ZFYVE1 by reducing PI3P levels. | ||||||
SAR405 | 1523406-39-4 | sc-507416 | 1 mg | $125.00 | ||
SAR405 is a VPS34 inhibitor. By inhibiting VPS34, SAR405 decreases the levels of PI3P, which is essential for ZFYVE1's role in the autophagy pathway, thus functionally inhibiting ZFYVE1. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor. Since ZFYVE1 has been implicated in signaling pathways involving MAPKs, inhibiting p38 MAPK can disrupt signals that may regulate the function of ZFYVE1, leading to its functional inhibition. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is an inhibitor of MEK1/2, upstream kinases in the MAPK/ERK pathway. As the MAPK/ERK pathway can regulate autophagy and endosomal dynamics, in which ZFYVE1 is involved, U0126 can indirectly inhibit ZFYVE1's function by altering signaling through this pathway. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Similar to U0126, PD98059 is an inhibitor of MEK, which can alter the MAPK/ERK signaling pathway. This alteration can indirectly lead to the functional inhibition of ZFYVE1 by disrupting the signaling that may regulate its activity. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $98.00 $255.00 $765.00 $1457.00 | 280 | |
Bafilomycin A1 is a known inhibitor of the vacuolar-type H+-ATPase (V-ATPase). By inhibiting V-ATPase, it prevents the acidification of endosomes and lysosomes, which is a process necessary for the function of ZFYVE1 in endosomal trafficking. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine is an antimalarial drug that also inhibits autophagy by increasing the pH in lysosomes and autophagosomes. Since ZFYVE1 is associated with early autophagosomal membranes, the increase in pH caused by Chloroquine can inhibit its function. | ||||||